News | 07 February 2022
India grants Emergency Use Authorisation to Sputnik Light
This is the ninth Covid-19 vaccine approved in India
This is the ninth Covid-19 vaccine approved in India
Key takeaways of recent quarter & conference call highlights
Pfizer and Moderna are also working on vaccines that target the Omicron variant
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
IOL Chemicals and Pharmaceuticals has reported standalone financial results for the period ended December 31, 2021
Dishman Carbogen Amcis has reported consolidated financial results for the period ended December 31, 2021
Sanofi unveiled a new bold and unifying corporate brand that supports the modernization and transformation the company launched in December 2019
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Lupin has reported consolidated financial results for the period ended December 31, 2021
The company has reported standalone financial results for the period ended December 31, 2021.
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
Highest safety and efficacy of Sputnik V confirmed during clinical trials and in real-world use in more than 60 countries around the world
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
The need is to vaccinate people who have not contracted Covid-19
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
The acquisition will allow Dr. Reddy's to build on Nimbus Health's strengths and introduce medical cannabis-based medicines as a promising treatment option for patients
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Subscribe To Our Newsletter & Stay Updated
